Purchase Order 75N93018P01157
Award Date
8/24/18
Potential Completion Date
8/23/19
Potential Value
$41K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Charles River Laboratories, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Wilmington, MA 01887, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $135,865.00 firm fixed-price purchase order to Charles River Laboratories, Inc. (doing business as Charles River) to manufacture and characterize Pichia working and master cell banks. This contract is not associated with any set-aside designation. Charles River is a contract research company that provides products and services to support pharmaceutical and...
Charles River Laboratories, Inc., doing business as Charles River, has been awarded a firm fixed price purchase order valued at one hundred twenty-one thousand one hundred fifty-five dollars by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide preparation services for a Pichia pastoris strain 230 master cell bank for malaria vaccine development. The work will be performed in Wilmington, Massachusetts over a two month period concluding in...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. (doing business as Charles River) on November 17, 2009. The $16,770 firm-fixed-price purchase order is for unspecified products and services related to a "MASTER PROTOCOL #LID-&E (PAI PROPOSAL#PMD06UJ9)". The award does not have a set-aside designation. Charles River is a global contract...
This is a federal contract award to Charles River Laboratories, Inc. (Charles River) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $187,327.80 firm fixed-price contract is for the manufacture and safety testing of experimental virus vaccines. The contract does not have a set-aside designation. Charles River is a leading provider of research products and services to government agencies, including laboratory...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Charles River Laboratories, Inc. (doing business as Charles River) to perform engineering run-microbial cell testing to determine growth curve of master cell bank (MCB) material. The $5,675 contract has a completion date of March 20, 2019 and was awarded on March 21, 2018. Charles River is a global company that provides...
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. (Charles River) for the manufacture and safety testing of experimental virus vaccines. The contract has a ceiling value of $172,286.40 and a completion date of June 11, 2013. This contract is not associated with a set-aside program. Charles River is a global contract...
This federal contract award, valued at $164,622.60, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. for the manufacture and safety testing of experimental virus vaccines. The contract is a delivery order with a firm fixed price. Charles River Laboratories is a global contract research organization that provides a wide range of research-related products and services to government agencies, including laboratory animals, diagnostic...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Charles River Laboratories, Inc. (doing business as Charles River) for the manufacture and safety testing of experimental virus vaccines. The contract has a ceiling value of $180,478.80 and is a firm fixed-price delivery order with a final completion date of July 31, 2020. The contract was not set aside for any specific business type. Through this award, Charles River,...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. (Charles River) for the manufacture and safety testing of experimental virus vaccines. The contract has a ceiling value of $11,445.30 and was awarded on December 17, 2014, with a completion date of December 16, 2015. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation....
This $186,389.10 firm fixed-price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. to manufacture and safety test experimental virus vaccines. The contract, which does not have a set-aside designation, was awarded on February 10, 2015 with an ultimate completion date of August 9, 2016. Charles River Laboratories is a global contract research organization...